IceCure Medical Ltd
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ICCM | ARAY | 584.SI | MDX.V | BDMD | PROF | |
|---|---|---|---|---|---|---|
| Market cap | 3.67M | 17.81M | 7.53M | 16.40M | 3.50M | 261.63M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.2 | -0.6 | — | — | 0.8 | -12.2 |
| Price/book | 0.2 | 0.4 | -2.0 | -1.5 | 0.1 | 5.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −96.38% | −90.34% | −60.00% | −16.67% | −90.00% | +19.28% |
| Today | +2.54% | +3.97% | 0.00% | 0.00% | −6.75% | +2.43% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ICCM news ›Critical Contrast: Embecta (NASDAQ:EMBC) & IceCure Medical (NASDAQ:ICCM)
Posted by Michael Walen on Nov 4th, 2026 Embecta (NASDAQ:EMBC – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two…
Lower Contrast Dose With Virtual Monoenergetic Imaging Shows Promise After Kidney Cryoablation
Bioengineer.org News Source: Nathaniel Bowman. (November 4, 2026). Lower Contrast Dose With Virtual Monoenergetic Imaging Shows Promise After Kidney Cryoablation. Scienmag.
IceCure Medical shareholders approve meeting agenda
uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease SEGG Media Reports More Than 1,500% Year-Over-Year Revenue Growth in Second…
IceCure Medical proposes 40-for-1 cap on reverse splits
Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue Growth of 96% Y/Y; Raises FY 2026 Revenue Guidance to 91% Y/Y Growth and U.S. Comm Revenue Guidance to 143% Y/Y, Crushing Consensus Expectations uniQure Announces…
IceCure Medical CEO reports 405K-unit stock grant
Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue Growth of 96% Y/Y; Raises FY 2026 Revenue Guidance to 91% Y/Y Growth and U.S. Comm Revenue Guidance to 143% Y/Y, Crushing Consensus Expectations uniQure Announces…
Doctors in St. Louis are seeing good results from a non-surgical method of killing breast tumors
October is Breast Cancer Awareness Month and we've learned about a procedure that's being used instead of traditional surgery if doctors find a lump. It's called Cryoablation. It kills tumors by freezing them with extremely cold…
Financial Analysis: IceCure Medical (ICCM) & Its Competitors
Posted by Defense World Staff on Oct 31st, 2026 IceCure Medical (NASDAQ:ICCM – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its competitors? We will…
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
--IceCure Medical Ltd., developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced the addition of Legacy Health in Portland, Oregon, with its Legacy…
IceCure Medical Ltd. Adds Adventist Health Glendale As U.S. Clinical Site For Its Post-Marketing ChoICE Study For Low-Risk Breast Cancer Cryoablation Treatment
IceCure Medical Ltd. announced that Adventist Health Glendale in Glendale, California has signed an agreement and received approval from the Institutional Review Board to become the first clinical... announced that Adventist Health…
More from 1 other outlet
Icecure Medical Receives Regulatory Approval to Market Prosense in China
IceCure Medical Ltd. has received approval, as a Class III medical device, from China's National Medical Products Administration for its ProSense system and associated cryoprobes. The NMPA approval... has received approval, as a Class III…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net7
- marketscreener.com4
- defenseworld.net2
- nasdaq.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.